Johnson & Johnson
JNJ153.240USD
Today
-4.12%
5 Days
-6.38%
1 Month
-7.19%
6 Months
-4.39%
Year to Date
+5.96%
1 Year
+0.55%
Agency Rating
Analyst Rating
Peer Comparison
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
News
Over 60,000 claims filed! Can Johnson & Johnson escape? The judge's stance is unwavering!
Johnson & Johnson (JNJ) is trying to handle claims through a bankruptcy plan. But the judge rejected it. The stock price may continue to decline.
US judge rejects J&J's $10 billion baby powder settlement
NEW YORK, March 31 (Reuters) - A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's JNJ.N $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
What Are Defensive Stocks? Should You Buy Them Now? Are Defense Stocks Defensive?
TradingKey - Defensive stocks are seen as "safe havens" during economic downturns because their products or services maintain stable demand regardless of economic cycles. Warren Buffett’s investment success is largely attributed to his preference for defensive blue-chip stocks.
Worried About a Recession? 1 Healthcare Dividend Stock That Has Thrived In Every Market Crash
TradingKey - One of those sectors is healthcare and one of the biggest healthcare companies around is Johnson & Johnson (NYSE: JNJ), a company that also pays a decent dividend to shareholders.
Johnson & Johnson Medtech Shockwave Medical Announces U.S. Launch Of Shockwave Javelin Peripheral IVL Catheter
March 4 (Reuters) - Johnson & Johnson JNJ.N:JOHNSON & JOHNSON MEDTECH: SHOCKWAVE MEDICAL ANNOUNCES U.S. LAUNCH OF SHOCKWAVE JAVELIN PERIPHERAL IVL CATHETER
BUZZ-Johnson & Johnson falls after 2025 forecast hit from stronger dollar
Updates** Shares of Johnson & Johnson JNJ.N falls 3.56% to $142.81** For 2025, co sees operational sales between $90.9 billion and $91.7 billion and adj operational EPS to be in the range of $10.75 to $10.95** Co sees a 25-cent hit from a stronger dollar, which was above expectations, at least...
